This workshop will provide attendees with an overview of various factors that may affect pulmonary outcomes in CF. Topics will include the CF microbiome, effects of azithromycin, pulmonary exacerbations and real world experience with CFTR modulators. The session will include information applicable to both pediatric and adult CF care.
Analyze important respiratory health issues related to the microbiome.
Review benefits and risks of azithromycin use in CF.
Summarize the consequences of lack of recovery from pulmonary exacerbations and new data on effectiveness of lumacaftor/ivacaftor.